|
US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts |
|
The US generics market was estimated at US$18.1 billion in 2004; the leading European generics markets together totalled between US$10-US$11 billion for the same period. This new report asks why there is such a difference in value?
|
|
Read more...
|
|
|
Indian Generics 2008-2012: The Growing Threat to Westernised Markets |
|
Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world.
|
|
Read more...
|
|
|
|
|
